Bit.bio raised $50m in Series C funding round led by M&G Investments.
29 December 2025
29 December 2025
Total investments received (USD): 224.97M
Round value (USD): 50M
Company: bit.bio
Related deals
Cloudsmith raised a $72 million Series C led by TCV and with participation from Insight Partners
Investments
08 April 2026
Storm Therapeutics received a $56 million Series C from investors including M Ventures, Pfizer Ventures and Taiho Ventures.
Investments
05 April 2026
Immutrin in a £65M series A led by Frazier Life Sciences, joined by SR One, Qiming Venture Partners, Cambridge Enterprise Ventures and F-Prime
Investments
07 March 2026
R1 Therapeutics secured a $77.5 million Series A led by Abingworth, F-Prime Capital and DaVita Venture Group.
Investments
01 March 2026
Chemify in a $50 million equity deal series B Extension backed by Zeon ventures from Japan
Investments
14 February 2026
Belgium
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Italy
Portugal
Spain